Correlation Between Acumen Pharmaceuticals and AVROBIO
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and AVROBIO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and AVROBIO into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and AVROBIO, you can compare the effects of market volatilities on Acumen Pharmaceuticals and AVROBIO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of AVROBIO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and AVROBIO.
Diversification Opportunities for Acumen Pharmaceuticals and AVROBIO
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Acumen and AVROBIO is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and AVROBIO in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AVROBIO and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with AVROBIO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AVROBIO has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and AVROBIO go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and AVROBIO
If you would invest 140.00 in AVROBIO on September 2, 2024 and sell it today you would earn a total of 0.00 from holding AVROBIO or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. AVROBIO
Performance |
Timeline |
Acumen Pharmaceuticals |
AVROBIO |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acumen Pharmaceuticals and AVROBIO Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and AVROBIO
The main advantage of trading using opposite Acumen Pharmaceuticals and AVROBIO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, AVROBIO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will offset losses from the drop in AVROBIO's long position.Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
AVROBIO vs. Ocean Biomedical | AVROBIO vs. Enveric Biosciences | AVROBIO vs. Elevation Oncology | AVROBIO vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |